Top Markets
Coin of the day
ABL Diagnostics Société anonyme ABL Diagnostics Société anonyme

ABL Diagnostics Société anonyme

ABLD
株式のランク #26286
ABL Diagnostics Société anonyme provides proprietary molecular biology assays... ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and internationally. The company offers genotyping through NGS and sanger sequencing for human immunodeficiency virus, SARS CoV-2, hepatitis-C virus, mycobacterium tuberculosis, and 16S/18S RNA; ultragene assays for viral detection of SARS CoV-2, MonkeyPox, and Clostridium; microbiological specimen transport and collection kits, which include saliva preservation, wastewater collection, and surface collection kits, as well as inactivation and preservation solution; and instrument and consumables, such as DNA/RNA extraction system, real-time PCR system, liquid handling robot, NGS library preparation kit, and sanger sequencing reaction. It also provides digital solutions comprising analysis software, data hosting, lab automation, Nadis, and SeqHepB. The company sells its products directly, as well as through a network of distributors to academic clinical pathology labs, private reference labs, and researchers. The company was formerly known as Etablissements Fauvet Girel and changed its name to ABL Diagnostics Société anonyme in April 2022. The company is headquartered in Woippy, France. ABL Diagnostics Société anonyme is a subsidiary of Advanced Biological Laboratories (ABL) S.A.
株価
$2.61
時価総額
$41.93M
変化(1日)
-6.78%
変化(1年)
-50.24%
FR
取引 ABL Diagnostics Société anonyme (ABLD)

カテゴリー

ABL Diagnostics Société anonyme(ABLD)の配当利回りの履歴
ABL Diagnostics Société anonyme(銘柄コード: ABLD)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
ABL Diagnostics Société anonyme(ABLD)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)